Afternoon workouts may beat morning exercise for blood sugar control
NCT ID NCT05123963
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether exercising in the afternoon is better than the morning for improving blood sugar control in people with prediabetes. 48 participants will do high-intensity interval training three times a week for 12 weeks. Researchers will measure how the body stores and uses fat and sugar to see if timing makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- high-intensity interval training (HIIT) on a cycle ergometer
- What this could lead to
- If it works, this could show that simply changing when you exercise can improve blood sugar control and reduce the risk of type 2 diabetes.
- What could go wrong
- This is a small, early-phase study with only 48 people. The results may not apply to everyone, and it's possible that exercise timing makes little difference.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 48 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2021
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pre-diabetes: * Fasting plasma glucose: 6.1 to 6.9 mmol/L or * 2-hour plasma glucose post 75g OGTT: 7.8 to 11.0 mmol/L and * HbA1c: 6.0 to 6.4% * or Insulin resistant: glucose clearance rate ≤ 360 ml/kg/min as determined using the Oral Glucose Insulin Sensitivity Index at Time 120 min. * BMI \> 25 kg/m2 * To be willing and able to adhere to the specifications of the protocol; * To have signed an informed consent document indicating that they understood the purpose of and procedures required for the study and were willing to participate in the study. Exclusion Criteria: * overt cardiovascular disease as assessed by medical history, physical exam, and abnormal ECG * Treatment with any drug known to affect lipid or carbohydrate metabolism, except statins (to be stopped 3 weeks prior to study A), metformin or anti-hypertensive drugs (to be stopped 7 days prior to the studies); * presence of liver or renal disease other than uncomplicated NASH or mild isolated proteinuria; uncontrolled thyroid disorder; * Uncontrolled severe hypertension, systolic pressure ≥ 180 mm Hg or diastolic pressure ≥ 110 mm Hg; * History of ischemic heart disease, tachyarrhythmia, QT interval prolongation, risk factors for torsade de pointes (eg hypokalemia), or taking any medication known to prolong the QT interval; * History of serious gastrointestinal disorders (malabsorption, peptic ulcer, gastroesophageal reflux requiring surgery, etc.); * Presence of a pacemaker; * Having undergone a PET study or CT scan in the past year; * Any contraindication to stopping statins for 3 months and stopping an anti-hypertensive medication and metformin for 7 days; * smoking (\>1 cigarette/day) and/or consumption of \>2 alcoholic beverages per day; * No blood donation two month prior the study; * prior history or current fasting plasma cholesterol level \> 7 mmol/l or fasting TG \> 6 mmol/l.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prediabetic state are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre de recherche du CHUS
RECRUITINGSherbrooke, Quebec, J1H 5N4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Finger-Prick at the pharmacy could uncover silent diabetes
- A daily pill aims to stop overweight from turning into obesity and diabetes
- Could collagen supplements tame blood sugar spikes?
- Can short bursts of stairs beat a long walk for prediabetes?
- Brazilian diabetes prevention program aims to stop type 2 diabetes before it starts
- Personalized diet and exercise plan tested for lasting weight loss in middle-aged adults